Avalo Therapeutics, Inc.
abdakibart
hidradenitis suppurativa
Resolved
851days ago
Phase 2 readout · ~ Mar 8, 2024 estimated
What's at stake
Phase 2 trial results for abdakibart in hidradenitis suppurativa are due ~ Mar 8, 2024. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Br J Dermatol. 2015;173(6):1431-1439;”